- Home
- AORT
AORT
Artivion Inc.
as 06-20-2025 4:00pm EST
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | KENNESAW |
| Market Cap: | 1.0B | IPO Year: | 1993 |
| Target Price: | $32.00 | AVG Volume (30 days): | 305.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $21.97 - $32.33 | Next Earning Date: | 08-07-2025 |
| Revenue: | $390,084,000 | Revenue Growth: | 5.94% |
| Revenue Growth (this year): | 12.18% | Revenue Growth (next year): | 10.39% |
Stock Insider Trading Activity of Artivion Inc. (AORT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Stanton Marshall S. | AORT | SVP, Clinical & MD Affair | Jun 17 '25 | Sell | $29.50 | 15,000 | $442,500.00 | 65,436 | |
| Stanton Marshall S. | AORT | SVP, Clinical & MD Affair | Jun 13 '25 | Sell | $28.44 | 26,132 | $743,131.21 | 65,436 | |
| Holloway Jean F | AORT | SVP, General Counsel | May 27 '25 | Sell | $29.00 | 8,748 | $253,692.00 | 178,510 | |
| SEMEDO ANTHONY B. | AORT | Director | May 23 '25 | Sell | $28.47 | 5,200 | $148,054.40 | 33,059 | |
| Holloway Jean F | AORT | SVP, General Counsel | May 21 '25 | Sell | $29.00 | 9,926 | $287,854.00 | 178,510 | |
| Stanton Marshall S. | AORT | SVP, Clinical & MD Affair | May 9 '25 | Sell | $29.13 | 10,548 | $307,265.35 | 65,436 |
Latest Artivion Inc. News
AORT Breaking Stock News: Dive into AORT Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Artivion Insider Sold Shares Worth $442,500, According to a Recent SEC Filing
Argus Research
10 days ago
AORT: Raising target price to $31.00
PR Newswire
18 days ago
Artivion to Participate in Upcoming Investor Conferences
PR Newswire
24 days ago
Artivion Announces Closing of Transactions to Exchange $99.5 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock
Simply Wall St.
a month ago
Returns On Capital At Artivion (NYSE:AORT) Have Stalled
Argus Research
a month ago
AORT: Raising target price to $31.00
PR Newswire
a month ago
Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock
Argus Research
a month ago
AORT: Raising target price to $30.00
Compare AORT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AORT Artivion Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.